HomeFileStructural heart disease

Structural heart disease

View Category

Structural heart disease

EuroPCR 2023 | TAVR in Patients with Bicuspid Aortic Valve Stenosis

Bicuspid aortic valve (BAV) stenosis is the most common congenital valve disease, affecting up to 2% of...
solaci -
Learn More
Structural heart disease

EuroPCR 2023 |Chimney Stenting vs BASILICA for the Prevention of Coronary Obstruction during TAVR

Coronary obstruction is a complication from TAVR that can cause death (up to 50% mortality), even though...
solaci -
Learn More
Structural heart disease

EuroPCR 2023 |TAVR in Cardiogenic Shock

Patients presenting aortic stenosis with cardiogenic shock are at extreme risk, with 70% mortality until the aortic...
solaci -
Learn More
Structural Heart Disease

EuroPCR 2023 | Events after Redo TAVR in Balloon-Expandable Valves

With the treatment of aortic valve disease in younger patients, a significant number of them will need...
solaci -
Learn More
Mitral valve

Latest Developments in Tricuspid Regurgitation

The natural history of tricuspid regurgitation is associated to hospitalization for cardiac failure and mortality. This is...
solaci -
Learn More
Structural heart disease

Low Gradient Aortic Stenosis: Is Invasive Assessment Viable?

There is an important group of patients presenting low flow, low-gradient severe aortic stenosis (defined as mean...
solaci -
Learn More
Structural heart disease

Redo Surgical Aortic Valve Replacement after Prior Transcatheter vs Surgical Aortic Valve Replacement: A Growing Population

Transcatheter aortic valve replacement (TAVR) has evolved since it was first implemented, and it is now also...
solaci -
Learn More
Structural heart disease

BASILICA: a Complex Strategy, Yet Safe

Coronary artery obstruction (CAO) after TAVR is rare, but it entails extremely high mortality (50% or more),...
solaci -
Learn More